Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,980 |
| Other current assets | 460 |
| TOTAL | $2,440 |
| Non-Current Assets | |
| PPE Net | 2,320 |
| Other Non-Current Assets | 280 |
| TOTAL | $2,600 |
| Total Assets | $4,130 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 700 |
| Accounts payable and accrued liabilities | 1,410 |
| Accrued Expenses | 860 |
| Other current liabilities | 160 |
| TOTAL | $3,150 |
| Non-Current Liabilities | |
| Long Term Debt | 2,270 |
| Other Non-Current Liabilities | 60 |
| TOTAL | $2,460 |
| Total Liabilities | $5,630 |
| Shareholders' Equity | |
| Common Shares | 1 |
| Retained earnings | -41,920 |
| Other shareholders' equity | 39,969 |
| TOTAL | $-1,490 |
| Total Liabilities And Equity | $4,140 |